This chapter reviews literature and presents guidelines for understanding the desired and adverse cognitive events associated with nonstimulant psychotropic medication.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akdede, B. B. K., Alptekin, K., Kitis, A., Arkar, H. & Akvardar, Y. (2005). Effects of quetiapine on cognitive functions in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, 233−238.
Aminoff, M. J., Marshall, J., Smith, E., & Wyke, M. (1974). Cognitive function in patients on lithium therapy. British Journal of Psychiatry, 125, 109−112.
Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects upon learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195−1202.
Behrle, F. C., Elkin, M. T., & Laybourne, P. C. (1956). Evaluation of a conditioning device in the treatment of nocturnal enuresis. Pediatrics, 17, 849−856.
Biederman, J., Baldessarini, R. J., Goldblatt, A., Lapey, K. A., Doyle, A., & Hesslein, P. (1993). A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 805−813.
Block, R. I., DeVoe, M., Stanley, B., Stanley, M., & Pomara, N. (1985). Memory performance in individuals with primary degenerative dementia: Its similarity to diazepam-induced impairments. Experimental Aging Research, 11, 151−155.
Bonnel, H. L., Etevenon, P., Benyacoub, J., & Slowen, P. (1981). Intellectual efficiency in manic-depressive patients treated with lithium. Acta Psychiatrica Scandinavica, 64, 423−430.
Braff, D. L., & Saccuzzo, D. P. (1982). Effect of antipsychotic medication on speed of information processing in schizophrenic patients. American Journal of Psychiatry, 139, 1127−1130.
Brumback, R. A., & Staton, R. D. (1980). Neuropsychological study of children during and after remission and endogenous depressive episodes. Perceptual and Motor Skills, 50, 1163−1167.
Campbell, M., Small, A. M., Green, W. H., Jennings, M. A., Perry, R., Bennett, W. G., et al. (1982). Lithium and haloperidol in hospitalized aggressive children. Psychopharmacology Bulletin, 18, 126−130.
Christodoulous, G. N., Kokkevi, A., Lykouras, E. P., Stefanis, C. N., & Papadimitriou, G. N. (1981). Effects of lithium on memory. American Journal of Psychiatry, 18, 847−848.
Cleghorn, J. M., Kaplan, R. D., Szechtman, B., Szechtman, H., & Brown, G. M. (1990). Neuroleptic drug effects on cognitive function in schizophrenia. Schizophrenia Research, 3, 211−219.
Cole, S. O. (1986). Effects of benzodiazepines on acquisition and performance: A critical assessment. Neuroscience and Biobehavioral Reviews, 10, 265−272.
Cuesta, M. J., Peralta, V., Zarzuela, A. (2001). Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study.Schizophrenia Research, 48, 17−28.
deGier, J. J., 't Hart, B. J., Nelemans, F. A., & Bergman, H. (1981). Psychomotor performance and real driving performance of outpatients receiving diazepam. Psychopharmacology, 73, 340−344.
Department of Health and Human Services, United States Government (1982). Use of approved drugs for unlabeled indications. FDA Drug Bulletin, 12, 4−5.
Dietch, J. T., & Jennings, R. K. (1988). Aggressive dyscontrol in patients treated with benzodiazepines. Journal of Clinical Psychiatry, 49, 184−188.
DiMascio, A., Giller, D. R., & Shader, R. I. (1968). Behavioral toxicity of psychotropic drugs: III. Effects on perceptual and cognitive functions. Connecticut Medicine, 32, 771−775.
DiMascio, A., Heninger, G., & Klerman, G. L. (1964). Psychopharmacology of imipramine and desipramine: A comparative study of their effects in normal males. Psychopharmacologia, 5, 361−371.
Dugas, J. E. (1977). Mood elevation and medication. Diseases of the Nervous System, 38, 958.
Eitan, N., Levin, Y., Ben-Artzi, E., Levy, A., & Neumann, M. (1992). Effects of antipsychotic drugs on memory functions of schizophrenic patients. Acta Psychiatrica Scandinavica, 85, 74−76.
Fayen, M., Goldman, M. B., Moulthrop, M. A., & Luchins, D. J. (1988). Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms. American Journal of Psychiatry, 145, 483−486.
Ferguson, H. B., & Simeon, J. G. (1984). Evaluating drug effects on children's cognitive functioning. Progress in Neuropsychopharmacology and Biological Psychiatry, 8, 683−686.
Gardos, G. (1980). Disinhibition of behavior by antianxiety drugs. Psychosomatics, 21, 1025-1026.
Ghoneim, M. M., & Mewaldt, S. P. (1990). Benzodiazepines and human memory: A review. Anesthesiology, 72, 926−938.
Glass, R. M., Uhlenhuth, E. H., Hartel, F. W., Matuzas, W., & Fischman, M. W. (1981). Cognitive dysfunction and imipramine in outpatient depressives. Archives of General Psychiatry, 38, 1048−1051.
Glass, R. M., Uhlenhuth, E. H., & Weinreb, H. (1978). Imipramine-reversible cognitive deficit in outpatient depressives. Psychopharmacology Bulletin, 14, 10−11.
Golombok, S., Moodley, P., & Ladner, M. (1988). Cognitive impairment in long term benzodiazepine users. Psychological Medicine, 18, 365−374.
Good, K. P., Kiss, I., Buiteman, C., Woodley, H., Rui, Q., Whitehorn, D. & Kopala, L. (2002). Improvement in cognitive functioning in patients with first episode psychosis during treatment with quetiapine: an interim analysis. British Journal of Psychiatry, 181(Suppl. 43), s45-s49.
Gotestam, K. G., & Anderson, B. E. (1978). Subjective effects and vigilance after diazepam and oxazepam in normal subjects. Acta Psychiatrica Scandinavica, 274(Suppl.), 117-128.
Green, M. F., Marshall, B. D., Wirshing, W. C., Ames, D., Marden, S. R., McGurk, S., Kern, R. S., & Mintz, J. (1997). Does risperidone improve verbal working memory in treatment-resistant schizophrenia. The American Journal of Psychiatry, 154, 799-804.
Guatrieri, C. T., & Patterson, D. R. (1986). Neuroleptic-induced tics in two hyperactive children. American Journal of Psychiatry, 143, 1176-1177.
Hawkins, K. A., Mohamed, S., & Woods, S. W. (1999). Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia. Psychological Medicine, 29, 1-8.
Harvey, P. D. (2003). Ziprasidone and cognition: the evolving story. Journal of Clinical Psychiatry, 64(Suppl. 19), 33-39.
Healey, M., Pickens, R., Meisch, R., & McKenna, T. (1983). Effects of clorazepate, diazepam, lorazepam and placebo on human memory. Journal of Clinical Psychiatry, 44, 436-439.
Helper, M. M., Wilcott, R. C., & Garfield, S. L. (1963). Effects of chlorpromazine on learning and related processes in emotionally disturbed children. Journal of Consulting Psychology, 27, 1-9.
Henry, G. M., Weingartner, H., & Murphy, D. L. (1973). Influence of affective states and psychoactive drugs on verbal learning and memory. American Journal of Psychiatry, 130, 966-971.
Hobi, V., Gastpar, M., Gastpar, G., Gilsdorf, U., Kielholz, P., & Schwarz, E. (1982). Driving ability of depressive patients under antidepressants. Journal of International Medical Research, 10, 65-81.
Huey, L. Y., Janowsky, D. S., Judd, L. L., Abrams, A., Parker, D., & Clopton, P. (1981). Effects of lithium carbonate on methylphenidate-induced mood, behavior and cognitive process. Psychopharmacology, 73, 161-164.
Israel, M., & Beaudry, P. (1988). Carbamazepine in psychiatry: A review. Canadian Journal of Psychiatry, 33, 577-584.
Jani, N. N., & Wise, T. N. (1988). Antidepressants and inhibited female orgasm: A literature review. Journal of Sex and Marital Therapy, 14, 279-284.
Judd, L. L., Hubbard, B., Janowsky, D. S., Huey, L. Y., & Takahashi, K. I. (1977). The effect of lithium carbonate on the cognitive functions of normal subjects. Archives of General Psychiatry, 34, 355-357.
Kardash, S., Hillman, E. S., & Werry, J. (1968). Efficacy of imipramine in childhood enuresis: A double-blind control study with placebo. Journal of the Canadian Medical Association, 99, 263-266.
Keeler, M. H., Prange, A. J., & Reifler, C. B. (1966). Effects of imipramine and thioridazine on set and action. Diseases of the Nervous System, 27, 798-802.
King, D. J. (1990). The effect of neuroleptics on cognitive and psychomotor function. British Journal of Psychiatry, 157, 799-811.
Koelega, H. S. (1989). Benzodiazepine and vigilance performance: A review. Psychopharmacology, 98, 145-156.
Kornetsky, C., Williams, J. E. G., & Bird, M. (1990). Attentional and motivational effects of psychoactive drugs. NIDA Research Monograph, 97, 177-192.
Kowatch, R. A., Fristad, M., Birmaher, B., Wagner, K. D., Findling, R. L. & Hellander, M. (2005). Treatment guidelines for children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 44, 213-235.
Kupietz, S. S., & Balka, E. B. (1976). Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy. Psychopharmacology, 50, 29-33.
Kusumo, K. S., & Vaughn, M. (1977). Effects of lithium salts on memory. British Journal of Psychiatry, 131, 453-457.
Lamping, D. L., Spring, B., & Gelenberg, A. J. (1984). Effects of two antidepressants on memory performance in depressed outpatients: A double blind study. Psychopharmacology, 84, 254-261.
Legg, J. F., & Stiff, M. P. (1976). Drug-related test patterns of depressed patients. Psychopharmacology, 50, 205-210.
Lister, R. G. (1985). The amnestic actions of benzodiazepines in man. Neuroscience & Biobehavioral Reviews, 9, 87-94.
Livingston, R. L., Zucker, D. K., Isenberg, K., & Wetzel, R. D. (1983). Tricyclic antidepressants and delirium. Journal of Clinical Psychiatry, 44, 173-176.
Lucki, I., Rickels, K., Giesecke, M. A., & Geller, A. (1987). Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. British Journal of Clinical Pharmacology, 23, 207-211.
Marusarz, T. Z., Wolpert, E. A., & Koh, S. D. (1981). Memory processing with lithium carbonate. Journal of Clinical Psychiatry, 42, 190-192.
McClellan, J. (2005). Commentary: Treatment guidelines for child and adolescent bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 236-239.
Meador-Woodruff, J. H., Akil, M., Wisner-Carlson, R., & Grunhaus, L. (1988). Behavioral, and cognitive toxicity related to elevated plasma tricyclic antidepressant levels. Journal of Clinical Psychopharmacology, 8, 28-32.
Miller, N. S., & Gold, M. S. (1990). Benzodiazepine tolerance, dependence, abuse and addiction. Journal of Psychoactive Drugs, 22, 23-33.
Murphy, D. L. (1977). The behavioral toxicity of monoamine oxidase-inhibiting antidepressants. Advances in Pharmacology and Chemotherapy, 14, 71-105.
Petrie, W. M. (1980). Sexual effects of antidepressants and psychomotor stimulant drugs. Modern Problems of Pharmacopsychiatry, 15, 77-90.
Peuskens, J., Demily, C., & Thibaut, F. (2005). Treatment of cognitive dysfunction in schzophrenia. Clinical therapeutics: The International Peer-reviewed Journal of Drug Therapy, 27(Suppl 1). Retrieved August 3, 2006 from http://www/sciencedirect.com/journal/01492918
Pishkin, V., Fishkin, S. M., Shurley, J. T., Lawrence, B. E., & Lovallo, W. R. (1978). Cognitive and psychophysiologic response to doxepin and chlordiazepoxide. Comprehensive Psychiatry, 19, 171-178.
Quinn, P. O., & Rapoport, J. L. (1975). One year follow-up of hyperactive boys treated with imipramine or methylphenidate. American Journal of Psychiatry, 132, 241-245.
Rapoport, J. (1965). Childhood behavior and learning problems treated with imipramine. International Journal of Psychiatry, 1, 635-642.
Rapoport, J. L., Quinn, P. O., Bradbard, G., Riddle, K. D., & Brooks, E. (1974). Imipramine and methylphenidate treatments of hyperactive boys. Archives of General Psychiatry, 30, 789-793.
Riddle, M. A., Nelson, J. C., Kleinman, C. S., Rasmusson, A., Leckman, J. F., King, R. A., & Cohen, D. J. (1991). Sudden death in children receiving norpramin: A review of three reported cases and commentary. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 845-846.
Rivas-Vazquez, R. A., Blais, M. A., Rey, G. J. & Rivaz-Vazquez, A. A. (2000). Atypical antipsychotic medications: pharmacological profiles and psychological implications. Professional Psychology: Research and Practice, 31, 628-640.
Rosenbaum, J. F., & Pollack, M. H. (1988). Anhedonic ejaculation with desipramine. International Journal of Psychiatry in Medicine, 18, 85-88.
Ross, R. J., Smallberg, S., & Weingartner, H. (1984). The effects of desmethylimipramine on cognitive function in healthy subjects. Psychiatry Research, 12, 89-97.
Rossi, A., Daneluzzo, E., Tomassini, A., Struglia, F., Cavallaro, R., Smeraldi, E. & Stratta, P. (2006). The effect of verbalization strategy on Wisconsin card sorting test performance in schizophrenic patients receiving classical or atypical antipsychotics. BMC Psychiatry, 6. Retrieved August 3, 2006, from http://www.biomedcentral.com/1471-244x/6/3
Segraves, R. T. (1988). Psychiatric drugs and inhibited female orgasm. Journal of Sex and Marital Therapy, 14, 202-207.
Sharma, T. (1999). Cognitive effects of conventional and atypical antipsychotics in schizophrenia. The British Journal of Psychiatry, 174(Suppl. 38), 44-51.
Shay, J., Sanchez, L. E., Cueva, J. E., Armenteros, J. L., Overall, J. E., & Campbell, M. (1993). Neuroleptic-related dyskinesias and stereotypes in autistic children: Videotaped ratings. Psychopharmacology Bulletin, 29, 359-363.
Shen, W. W., & Lindbergh, S. S. (1990). Inhibited female orgasm resulting from psychotropic drugs: A five year updated clinical review. Journal of Reproductive Medicine, 37, 11-14.
Silva, R. R., Malone, R. P., Anderson, L. T., Shay, J., & Campbell, M. (1993). Haloperidol withdrawal and weight changes in autistic children. Psychopharmacology Bulletin, 29, 287-291.
Sliwa, J. A., & Lis, S. (1993). Drug-induced dysphagia. Archives of Physical Medicine and Rehabilitation, 74, 445-447.
Spiegel, D. E., & Keith-Spiegel, P. (1967). The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients. The Journal of Nervous and Mental Disease, 144, 111-116.
Sprague, R. L., Barnes, K. R., & Werry, J. S. (1970). Methylphenidate and thioridazine: Learning, reaction time, activity and classroom behavior in disturbed children. American Journal of Orthopsychiatry, 40, 615-628.
Squire, L. R., Judd, L. L., Janowsky, D. S., & Huey, L. Y. (1980). Effects of lithium carbonate on memory and other cognitive functions. American Journal of Psychiatry, 137, 1042-1046.
Staton, R. D., Wilson, H., & Brumback, R. A. (1981). Cognitive improvement associated with tricyclic antidepressant treatment of childhood major depressive illness. Perceptual and Motor Skills, 53, 219-234.
Stenberg, A., & Lackgren, G. (1994). Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics, 94, 841-846.
Sternberg, D. E., & Jarvik, M. E. (1976). Memory functions in depression. Archives of General Psychiatry, 33, 219-224.
Stip, E., Chouinard, S., & Boulay, L. J. (2005). On the trial of a cognitive enhancer for the treatment of schizophrenia. Progress in Neuro-psychopharmacology & Biological Psychiatry, 29, 219-232.
Strauss, W. H., & Kleiser, E. (1990). Cognitive disturbances in neuroleptic therapy. Acta Psychiatrica Scandinavica, 82 (Suppl. 358), 56-57.
Strauss, W. H., Kleiser, E., & Leuthcke, H. (1988). Dyscognitive syndromes in neuroleptic therapy. Pharmacopsychiatry, 21, 298-299.
Sweeney, J. A., Keilp, J. G., Haas, G. L., Hill, J., & Weiden, P. J. (1991). Relationships between medication treatments and neuropsychological test performance in schizophrenia. Psychiatry Research, 37, 297-308.
Thienhaus, O. J., Allen, A., Bennett, J. A., Chopra, Y. M., & Zemlan, F. P. (1990). Anticholinergic serum levels and cognitive performance. European Archives of Psychiatry and Clinical Neuroscience, 240, 28-33.
Thompson, P. J. (1991). Antidepressants and memory: A review. Human Psychopharmacology, 6, 79-90.
Thompson, P. J., & Trimble, M. R. (1982). Non-MAOI antidepressant drugs and cognitive functions: A review. Psychological Medicine, 12, 539-548.
Tingelstad, J. B. (1991). The cardiotoxicity of the tricyclics. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 845-846.
Weickert, T. W., Goldberg, T. E., Marenco, S., Bigelow, L. B., Egan, M. F. & Weinberger, D. R. (2003). Comparison of cognitive performance during a placebo period and an atypical antipsychotic treatment period in schizophrenia: critical examination of confounds. Neuropsychopharmacology, 28, 1491-1500.
Weise, C. C., O'Reilly, P. P., & Hesbacher, P. (1972). Perphenazine-amitriptyline in neurotic underachieving students: A controlled study. Diseases of the Nervous System, 33, 318-325.
Weiss, A. A., Robinson, S., & Dasberg, H. (1973). Changes in mental functioning accompanying antipsychotic drug therapy. Annals of Psychiatry and Related Disciplines, 11, 134-140.
Werry, J. S., Aman, M. G., & Diamond, E. (1979). Imipramine and methylphenidate in hyperactive children. Journal of Child Psychology and Psychiatry, 21, 27-35.
Werry, J. S., Dowrick, P. W., Lampen, E. L., & Vamos, M. J. (1975). Imipramine in enuresis—Psychological and physiological effect. Journal of Child Psychology and Psychiatry, 16, 289-299.
Werry, J. S., Weiss, G., Douglas, V., & Martin, M. A. (1966). Studies on the hyperactive child: The effect of chlorpromazine upon behavior and learning ability. Journal of the American Academy of Child Psychiatry, 5, 292-312.
Wittenborn, J. R. (1988). Assessment of the effect of drugs on memory. Psychopharmacology Series, 6, 67-78.
Woodward, N. D., Purdon, S. E., Meltzer, H. Y. & Zald, D. H. (2005). A meta-analysis of neuropsychological change to clozapine, olanzepine, quetiapine, and risperidone in schizophrenia. International Journal of Neuropsychopharmacology, 8, 457-472.
Wright, P. & O’Flaherty, L. (2003). Antipsychotic drugs: atypical advantages and typical disadvantages. Irish Journal of Psychological Medicine, 20, 24-27.
Zimmermann-Tansella, C. (1984). Psychological performance of normal subjects on tasks commonly used in evaluation of anxiolytic drugs. Perceptual and Motor Skills, 58, 803-810.
Zisook, S., & DeVaul, R. (1977). Adverse behavioral effects of benzodiazepines. The Journal of Family Practice, 5, 963-966.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cepeda, M.L. (2009). Nonstimulant Psychotropic Medication: Desired and Adverse Cognitive Events. In: Reynolds, C.R., Fletcher-Janzen, E. (eds) Handbook of Clinical Child Neuropsychology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-78867-8_23
Download citation
DOI: https://doi.org/10.1007/978-0-387-78867-8_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-70708-2
Online ISBN: 978-0-387-78867-8
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)